Preliminary Analysis of the Association Between Therapeutic-Dose Anticoagulation and Long Term Outcomes from the ACTIV-4a and ATTACC Multiplatform Adaptive Trial of Hospitalized Patients with COVID-19

Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSPGREENSTEIN, Y. Y.HUBEL, K.VENUGOPAL, V.LAI, Y.BERGER, J. S.CHANG, S. Y.COLOVOS, C.SHAH, F. A.ISLAM, M.CEJA, J. JimenezKHAN, M.KORNBLITH, L. Z.LAWLER, P. R.GADDH, M.MOISES, J.GUERRERO, R. MorilloNKEMDIRIM, W.REYNOLDS, H. R.AMIGO, J. SeijasSOEIRO, A.WAHID, L.ZAHRA, A.GOLIGHER, E. C.ZARYCHANSKI, R.CUSHMAN, M.GONG, M. N.2022-07-222022-07-222022AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, v.205, suppl.S, 20221073-449Xhttps://observatorio.fm.usp.br/handle/OPI/47715engrestrictedAccessPreliminary Analysis of the Association Between Therapeutic-Dose Anticoagulation and Long Term Outcomes from the ACTIV-4a and ATTACC Multiplatform Adaptive Trial of Hospitalized Patients with COVID-19conferenceObjectCopyright AMER THORACIC SOCCritical Care MedicineRespiratory System1535-4970